Matt Bull

Matt Bull is a seasoned professional with a wealth of experience in the pharmaceutical industry, specializing in oncology, hematology, and rare diseases.

Currently serving as the Business Unit Director for oncology and hematology at Amgen, Matt has held various key leadership roles at Novartis, including Franchise Head for Oncology and Business Franchise Head for rare diseases.

With a strong background in sales, marketing, and brand management, Matt has also excelled in roles such as National Sales and Marketing Manager, New Products Strategy Lead, and Brand Manager at Novartis.

His expertise extends to specialist training, field training, and hospital business management within the pharmaceutical sector.

Having worked as a medical sales representative at Aventis earlier in his career, Matt Bull brings a diverse skill set and a deep understanding of the healthcare landscape to his current role.

His extensive experience in pharmaceutical leadership and management positions him as a valuable asset in driving strategic growth and innovation within the industry.